Today: 3 July 2026
Browse Category

Mining Industry 18 February 2026 - 24 February 2026

ASX 200 slips after record run as Rio Tinto drags miners; QBE results set the tone for next week

ASX 200 slips after record run as Rio Tinto drags miners; QBE results set the tone for next week

Sydney, Feb 20, 2026, 21:30 AEDT — Market closed Australian stocks edged down Friday, giving up ground after reaching all-time highs, with Rio Tinto’s numbers dragging miners lower. The S&P/ASX 200 lost 4.8 points, closing at 9,081.4—snapping a four-session run-up. Still, the index managed a 1.8% weekly gain, having hit a record 9,118.3 just a day earlier.
20 February 2026
···
Glencore share price rises on $2 billion payout plan as Congo copper deal grabs attention

Glencore share price rises on $2 billion payout plan as Congo copper deal grabs attention

London, February 18, 2026, 09:02 GMT — Regular session Glencore plc shares rose about 3% to 500.45 pence by 0902 GMT on Wednesday after the Swiss-based miner and commodities trader set out a $2 billion shareholder payout with its 2025 results. Adjusted EBITDA — a measure of operating profit before interest, tax and some one-offs — fell 6% to $13.51 billion, above an analysts’ $13.3 billion consensus, and CEO Gary Nagle said “the underlying momentum in H2 was clear.” It comes weeks after rival Rio Tinto abandoned takeover talks.
18 February 2026
···
1 2 3 4 5 6 … 30

Stock Market Today

  • Proteomics International (ASX: PIQ) Soars 28% on Friday as Investors React to Regulatory and Commercial Moves
    July 3, 2026, 12:16 AM EDT. Shares of Proteomics International Laboratories Ltd (ASX: PIQ) shot up 28.13% to AUD 0.20 on Friday after the company announced steps forward in its precision diagnostics and proteomics technology platform. The move comes as PIQ works on expanding its commercial footprint, securing regulatory clearances, and building up globally. The company said it's working to grow product adoption through new partnerships and continued research. Main push comes from recent regulatory progress, wider distribution, and more money going into new projects. But the company still faces regulatory risk, rivals, funding questions, and tough broader markets as a small-cap. Investors are tracking news on commercial deals and the next round of regulatory news that could move the stock again.
Go toTop